Cell Signaling Technology Logo
1% for the planet logo
Trial Size Available Flag
Recombinant Flag
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

Iduronate 2-Sulfatase (F5F9E) Rabbit mAb #86051

Filter:
  • WB

    Supporting Data

    REACTIVITY H M R
    SENSITIVITY Endogenous
    MW (kDa) 80
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    Iduronate 2-Sulfatase (F5F9E) Rabbit mAb recognizes endogenous levels of total iduronate 2-sulfatase protein.

    Species Reactivity:

    Human, Mouse, Rat

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro160 of human iduronate 2-sulfatase protein.

    Background

    Iduronate 2-sulfatase (IDS) is a lysosomal enzyme expressed in pancreatic islets responsible for proteoglycan degradation, such as dermatan sulfate and heparan sulfate. It has a role in glucose-stimulated insulin secretion via a mechanism involving exocytosis activation through phosphorylation of protein kinase C alpha (PKCα) and its Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) (1). IDS was shown to be glycosylated in the endoplasmic reticulum (ER) and Golgi apparatus and proteolytically cleaved to generate the mature forms in the Golgi apparatus. Mature IDS is then translocated to the lysosome (2). Mutations in the IDS gene cause the progressive disease mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, an X-linked recessive lysosomal storage disorder (2-4). Inactivity, insufficiency, or absence of IDS leads to widespread accumulation of proteoglycans and subsequent lysosomal dysfunction in multiple organs and tissues, including the central nervous system (CNS) (4).
    For Research Use Only. Not for Use in Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.